After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Liaohai “Leo” Chen, a research scientist who oversaw a $20 million surgical robotics training facility while at the ...

Over the last three months, we've seen significantly more insider buying, than insider selling, at Bristol-Myers Squibb.

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

Pune: Almost two weeks after registration for undergraduate courses announced by Maharashtra Common Entrance Test (CET) cell, the response to some pro.

To get a sense of who is truly in control of Bristol-Myers Squibb Company ( NYSE:BMY ), it is important to understand the ...

From January 14th to 16thArctech the world leading solar tracking and racking solutions provider participated in the World Future Energy Summit WFES 2025 at the ADNEC Exhibition Center Abu Dhabi UAE O ...

The Centers for Medicare and Medicaid Services (CMS) released its second round of drug negotiation targets, a list of 15 ...

These courses got the ‘professional' status only ... The CET cell is planning to reach out to BMS, BBA, and BCA colleges to promote CET on their portal. They are likely to approach the state ...

Speaking on condition of anonymity, a Barrick employee in Mali and a consultant for mining companies in the country said the gold was now being stored at BMS. In a Jan. 2 order seen by Reuters ...

The drug generated $4.4 billion in the first 9 months of 2024, but BMS expects an "additional step down” to $2 billion to $2.5 billion in 2025. In addition, Pomalyst and Sprycel are expected to ...